Header cover image

Taiwanese (TAIEX) Drug Retail Industry Analysis

UpdatedSep 30, 2025
DataAggregated Company Financials
Companies5
  • 7D-1.1%
  • 3M-5.6%
  • 1Y-31.5%
  • YTDn/a

Over the last 7 days, the Drug Retail industry has dropped 1.1%, driven by pullbacks from every company within the industry. However, the industry is down 31% over the past year. Looking forward, earnings are forecast to grow by 14% annually.

Industry Valuation and Performance

Has the Taiwanese Drug Retail Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 01 Oct 2025NT$28.5bNT$33.5bNT$755.9m28.9x37.8x0.9x
Fri, 29 Aug 2025NT$31.0bNT$33.5bNT$755.9m31.7x41x0.9x
Sun, 27 Jul 2025NT$31.2bNT$32.8bNT$754.7m27.4x41.3x0.9x
Tue, 24 Jun 2025NT$29.9bNT$32.8bNT$754.7m28.4x39.6x0.9x
Thu, 22 May 2025NT$32.6bNT$32.8bNT$754.7m31.2x43.3x1x
Sat, 19 Apr 2025NT$34.5bNT$32.3bNT$718.2m38.4x48x1.1x
Mon, 17 Mar 2025NT$37.7bNT$32.1bNT$701.3m45.6x53.7x1.2x
Wed, 12 Feb 2025NT$33.7bNT$31.8bNT$755.8m42x44.6x1.1x
Fri, 10 Jan 2025NT$32.4bNT$31.8bNT$755.8m43.3x42.8x1x
Sun, 08 Dec 2024NT$35.9bNT$31.8bNT$755.8m46.2x47.5x1.1x
Tue, 05 Nov 2024NT$39.0bNT$31.4bNT$774.1m112.2x50.4x1.2x
Thu, 03 Oct 2024NT$41.4bNT$31.0bNT$840.8m113.9x49.3x1.3x
Sat, 31 Aug 2024NT$41.4bNT$31.0bNT$840.8m112.4x49.2x1.3x
Mon, 29 Jul 2024NT$44.2bNT$30.7bNT$873.1m80.1x50.6x1.4x
Wed, 26 Jun 2024NT$45.5bNT$30.7bNT$873.1m80.3x52.1x1.5x
Fri, 24 May 2024NT$48.3bNT$30.7bNT$873.1m83.4x55.3x1.6x
Sun, 21 Apr 2024NT$48.7bNT$30.3bNT$935.7m57.9x52x1.6x
Tue, 19 Mar 2024NT$54.6bNT$30.3bNT$974.4m57.4x56.1x1.8x
Thu, 15 Feb 2024NT$56.3bNT$29.9bNT$964.0m62x58.4x1.9x
Sat, 13 Jan 2024NT$52.9bNT$26.8bNT$949.0m58.5x55.7x2x
Mon, 11 Dec 2023NT$53.5bNT$26.8bNT$949.0m59.3x56.4x2x
Wed, 08 Nov 2023NT$53.3bNT$26.3bNT$1.0b45.9x52.3x2x
Fri, 06 Oct 2023NT$54.7bNT$26.3bNT$1.0b47.4x53.6x2.1x
Sun, 03 Sep 2023NT$54.0bNT$26.3bNT$1.0b46.1x52.9x2.1x
Tue, 01 Aug 2023NT$55.1bNT$26.7bNT$1.3b26.4x43.6x2.1x
Thu, 29 Jun 2023NT$51.9bNT$26.8bNT$1.3b26.9x41.2x1.9x
Sat, 27 May 2023NT$50.8bNT$26.6bNT$1.3b23.1x39.9x1.9x
Mon, 24 Apr 2023NT$50.1bNT$25.9bNT$1.2b22.6x41.1x1.9x
Wed, 22 Mar 2023NT$45.9bNT$25.8bNT$1.2b16.8x37.6x1.8x
Fri, 17 Feb 2023NT$40.1bNT$25.1bNT$1.2b15.4x34.4x1.6x
Sun, 15 Jan 2023NT$37.9bNT$25.1bNT$1.2b15.6x32.5x1.5x
Tue, 13 Dec 2022NT$35.5bNT$25.1bNT$1.2b15.1x30.4x1.4x
Thu, 10 Nov 2022NT$32.2bNT$24.3bNT$1.1b20.2x30.6x1.3x
Sat, 08 Oct 2022NT$32.8bNT$24.3bNT$1.1b19.6x31.2x1.4x
Price to Earnings Ratio

31.2x


Total Market Cap: NT$32.8bTotal Earnings: NT$1.1bTotal Revenue: NT$24.3bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Drug Retail Industry Price to Earnings3Y Average 45.5x202320242025
Current Industry PE
  • Investors are pessimistic on the Taiwanese Drug Retail industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 37.8x which is lower than its 3-year average PE of 45.5x.
  • The 3-year average PS ratio of 1.5x is higher than the industry's current PS ratio of 0.85x.
Past Earnings Growth
  • The earnings for companies in the Drug Retail industry have declined 10% per year over the last three years.
  • Meanwhile revenues for these companies have grown 11% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Comparison

How does Taiwanese Drug Retail compare with similar industries?

TW Market-2.59%
Consumer Staples-0.20%
Food and Staples Retail0.026%
Drug Retail-1.09%
Food Distributors1.52%
Food Retail0.077%
Big Box Super Stores0%0
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
No data available

Latest News